One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A Blueprint for Assessing Affordability of SGLT2 Inhibitors in the United States: The Cost-Effectiveness of Dapagliflozin in Three European Countries.
Khine, Annika 1; Lin, Eugene 2,3,4
doi : 10.2215/CJN.09900822
Volume 17(12) pgs. 1707-1834 December 2022
Toward Guideline-Directed Medical Therapy in Nephrology: Lifetime Benefit of RAAS and SGLT2 Inhibition in Nondiabetic Kidney Disease.
Zeitler, Evan M.; Mottl, Amy K.
doi : 10.2215/CJN.12401022
Bardoxolone Methyl for Alport Syndrome: Opportunities and Challenges.
Quinlan, Catherine 1,2,3,4; Jayasinghe, Kushani 2,4,5,6
doi : 10.2215/CJN.12491022
Reproductive Health in Women with Kidney Disease.
Gumber, Ramnika 1; Shah, Silvi 2
doi : 10.2215/CJN.12461022
Symptom Burden before and after Dialysis Initiation in Older Patients.
de Rooij, Esther N.M. 1,2; Meuleman, Yvette 1; de Fijter, Johan W. 2; Jager, Kitty J. 3; Chesnaye, Nicholas C. 3; Evans, Marie 4; Caskey, Fergus J. 5; Torino, Claudia 6; Porto, Gaetana 7; Szymczak, Maciej 8; Drechsler, Christiane 9; Wanner, Christoph 9; Dekker, Friedo W. 1; Hoogeveen, Ellen K. 1,2,10,*; on behalf of the EQUAL study investigators; EQUAL study investigators; Schneider, Andreas; Torp, Anke; Iwig, Beate; Perras, Boris; Marx, Christian; Drechsler, Christiane;
doi : 10.2215/CJN.09190822
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease: A Health-Economic Analysis of DAPA-CKD.
McEwan, Phil 1; Darlington, Oliver 1; Miller, Ryan 1; McMurray, John J.V. 2; Wheeler, David C. 3; Heerspink, Hiddo J.L. 4,5; Briggs, Andrew 6; Bergenheim, Klas 7; Garcia Sanchez, Juan Jose 8
doi : 10.2215/CJN.03790322
Menstrual Abnormalities and Reproductive Lifespan in Females with CKD: A Systematic Review and Meta-Analysis.
Rytz, Chantal L. 1,2; Kochaksaraei, Golasa Samedi 2; Skeith, Leslie 3,4,5,6; Ronksley, Paul E. 2,3,5,6; Dumanski, Sandra M. 1,2,4,5,6; Robert, Magali 2,7; Ahmed, Sofia B. 1,2,4,5,6
doi : 10.2215/CJN.07100622
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes.
Vart, Priya 1,2; Vaduganathan, Muthiah 3; Jongs, Niels 1; Remuzzi, Giuseppe 4; Wheeler, David C. 5; Hou, Fan Fan 6; McCausland, Finnian 3; Chertow, Glenn M. 7,8; Heerspink, Hiddo J.L. 1,9
doi : 10.2215/CJN.08900722
Effects of Bardoxolone Methyl in Alport Syndrome.
Warady, Bradley A. 1; Pergola, Pablo E. 2; Agarwal, Rajiv 3; Andreoli, Sharon 4; Appel, Gerald B. 5; Bangalore, Sripal 6; Block, Geoffrey A. 7; Chapman, Arlene B. 8; Chin, Melanie P. 9; Gibson, Keisha L. 10; Goldsberry, Angie 9; Iijima, Kazumoto 11; Inker, Lesley A. 12; Kashtan, Clifford E. 13; Knebelmann, Bertrand 14; Mariani, Laura H. 15; Meyer, Colin J. 9; Nozu, Kandai 11; O'Grady, Megan 9; Rheault, Michelle N. 13; Silva, Arnold L. 16; Stenvinkel, Peter 17; Torra, Roser 18; Chertow, Glenn M. 19
doi : 10.2215/CJN.02400222
Nephrology Program Director Protected Time for Program Administration in the United States.
Yuan, Christina M. 1; Young, Brian Y. 2; Watson, Maura A. 1; Sussman, Amy N. 3
doi : 10.2215/CJN.09050822
The Accreditation Council for Graduate Medical Education (ACGME) required that program directors receive 10-20 h/wk of protected time for program administration (including didactic teaching).
Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes: 10-Year and Lifetime Risk Prediction Models.
Ostergaard, Helena Bleken 1; Read, Stephanie H. 2; Sattar, Naveed 3; Franzen, Stefan 4,5; Halbesma, Nynke 2; Dorresteijn, Jannick A.N. 1; Westerink, Jan 1; Visseren, Frank L.J. 1; Wild, Sarah H. 2; Eliasson, Bjorn 4,6; van der Leeuw, Joep 7,8
doi : 10.2215/CJN.05020422
A Survey of Environmental Sustainability Practices in Dialysis Facilities in Australia and New Zealand.
Talbot, Benjamin 1,2; Barraclough, Katherine 3,4; Sypek, Matthew 3,4; Gois, Pedro 5,6; Arnold, Leila 7; McDonald, Stephen 8; Knight, John 1,2,9
doi : 10.2215/CJN.08090722
Effect of Furosemide on Proximal Tubular Secretion of Organic Solutes in Patients Receiving Hemodialysis.
Sirich, Tammy L. 1,2; Hostetter, Thomas H. 3; Flythe, Jennifer E. 3,4
doi : 10.2215/CJN.08310722
Correction: Use and Outcomes of Induction Therapy in Well-Matched Kidney Transplant Recipients.
doi : 10.2215/CJN.10870922
Overview of the Medical Management of the Critically Ill Patient.
Martinez, Rebecca H. 1; Liu, Kathleen D. 1,2; Aldrich, J. Matthew 1
doi : 10.2215/CJN.07130622
How I Treat Focal Segmental Glomerulosclerosis.
Liew, Adrian 1; Gibson, Keisha L. 2
doi : 10.2215/CJN.06850622
Community Houses to Increase Access to Home Dialysis.
10.2215/CJN.09090822
doi : 10.2215/CJN.09090822
The Immune System and Idiopathic Nephrotic Syndrome.
Campbell, Ruth E.; Thurman, Joshua M.
doi : 10.2215/CJN.07180622
